Blueshift Asset Management, LLC Nevro Corp Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$138.17 - $184.34 $801,247 - $1.07 Million	-5,799 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $284,768 - $363,192	-2,496 Reduced 30.09%	5,799 $808,000
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $741,987 - $1.08 Million	8,295 New	8,295 $991,000
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $280,797 - $324,097	-4,838 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$35.52 - $62.62 $171,845 - $302,955	4,838 New	4,838 $302,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.